Physician profile
Stephanie Rivera
NPI 1538307509
$1,627.99
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $515 · 2022: $659 · 2023: $204 · 2024: $99.90 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $348.25 | 2022 | |
| Genentech USA, INC. | $150.00 | 2021 | |
| Kerecis Limited | $129.40 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Incyte Corporation | $129.38 | 2021 | |
| Novo Nordisk INC | $124.99 | 2022 | |
| Horizon Therapeutics Plc | $124.99 | 2023 | Uplizna |
| Csl Behring | $123.11 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $122.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $120.40 | 2025 | |
| Medical Device Business Services, INC. | $113.69 | 2021 | |
| Alnylam Pharmaceuticals INC. | $79.09 | 2023 | Amvuttra |
| Davol INC. | $31.91 | 2022 | |
| Ethicon US, LLC | $30.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.